GU NURSES CONNECT
@gunursesconnect
Followers
618
Following
2K
Media
454
Statuses
989
Independent Medical Education from COR2ED developed by GU NURSES CONNECT, experts in GenitoUrinary (GU) oncology nursing. https://t.co/PchtPfFT3b
Basel-Country 4103, Suiza
Joined August 2020
In this interactive mCRPC case study from Prof. Gunhild von Amsberg for @guconnectinfo you’ll learn how early treatment intensification with a PARPi plus ARPI can support improved outcomes. #ProstateOncology #PCSM
New patient case video! 📺 Shared decision-making for mCRPC patients: PART 2 Uro-Oncologist Prof. Gunhild von Amsberg continues to explore early treatment intensification with a PARPi plus ARPI combination -> You’ll also discover the 5-step SHARE Communication Framework to
0
0
0
Enhance patient discussions with the SHARE Communication Framework; a straightforward five-step guide to support shared, informed decision-making. Find out more in this interactive prostate cancer patient-case study video from experts in collaboration with @guconnectinfo
📣New! patient case video + shared decision-making tool for pts w/ mCRPC 📺 Discover the SHARE Communication Framework to use with your patients in this patient case video Video highlights PART 2 in this post (see part 1 in our previous post!) ~ Endorsed by Urobel &
0
0
1
🎉 @COR2EDMedEd now has over 20,000 YouTube subscribers! 🎉 GU NURSES CONNECT is an initiative of COR2ED - come and find us on YouTube! Join over 20k healthcare professionals who follow us on YouTube to stay up to date with high-quality, engaging medical education programmes
0
0
0
THE #ESMO25 COMPLETE Newsletter by OncoAlert 🚨IS OUT NOW‼️ TO GET IT REGISTER at https://t.co/yzt83gqQkF OR https://t.co/dq8GEzl9ps 5⃣0⃣of our pick of TOP Trials Presented in Berlin🇩🇪Divided by Tumor Type and with great video coverage by our collaborators at @COR2EDMedEd
1
12
31
🚨 Update on new #BladderCancer data from #ESMO25! Will the data impact clinical practice? Watch the video from our partner physician group @guconnectinfo to find out! #MedEd
Just released! Bladder cancer update from #ESMO25! 📺 Prof. Thomas Powles shares his bladder cancer highlights & reviews the latest data from KEYNOTE-905, ALBAN & Imvigor011. See more updates from ESMO: https://t.co/I55WRAbZDT This independent programme is supported by
0
0
0
New #RCC update from #ESMO25! Prof. Viktor Grünwald (@ViktorGruenwald) joined us at #ESMO to report on advanced renal cell carcinoma data from LenCabo, KEYMAKER-U03, and CLEAR studies He also reviews the use of [68 Ga]Ga-DPI-4452 (CAIX) PET/CT for staging of disease. 📺 Watch
0
0
1
📢 Come and visit us in Berlin at #ESMO25! We'll be at Booth 4025 offering FREE profile headshots from our professional photographer, and showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas. See you there! #IME
3
13
22
📢 Come and visit us in Berlin at #ESMO25! We'll be at Booth 4025 offering FREE profile headshots from our professional photographer & showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas. See you there! #IME #MedTwitter
0
13
14
New patient case video from our partner physician group @guconnectinfo! 📺 Shared decision-making for mCRPC patients: PART 2 Uro-Oncologist Prof. Gunhild von Amsberg continues to explore early treatment intensification with a PARPi plus ARPI combination -> You’ll also discover
0
0
0
New patient case video from our partner physician group @guconnectinfo 📺 Shared decision-making for mCRPC patients: PART 1 -> Explore early treatment intensification with a PARPi plus ARPI combination -> Discover the 5-step SHARE Communication Framework to support shared
1
0
1
Coming soon… An interactive case with Prof. Gunhild von Amsberg on shared decision-making for men with mCRPC. The patient case explores early intensification strategies and practical communication tools. Stay tuned for: 🔹 Practical SDM tools 🔹 Early treatment
0
0
3
🎉COR2ED has over 12k subscribers on YouTube! 🎉 Do you follow us? ▶️ https://t.co/jB6WsxAQmR Join over 12k HCPs on our YouTube channel and stay up to date with #MedEd videos as they’re released 🎓 #MedicalEducation #Oncology #GUtwitter #OncologyNursing #CancerNurses
1
0
2
How is molecular classification transforming prognosis and personalising treatment in endometrial cancer? Find out here: https://t.co/yPBSms8NZY
#MedEd #Oncology #PrecisionMedicine #OBGYN This educational programme is sponsored by an Independent Educational Grant from Eisai
cor2ed.com
This video, led by Prof. Christian Marth, explores the latest treatment strategies for advanced/recurrent endometrial cancer. It highlights the shift from
🎓 New Endometrial Cancer #MedEd Programme Prof. Christian Marth explores the current treatment strategies for advanced/recurrent #endometrialcancer 📺 Watch the video below See more of the programme & get the slides: https://t.co/JRBC6VZfWe This educational programme is
0
0
0
Join Leading Experts & @COR2EDMedEd for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: https://t.co/7O0D3qP3WQ a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.
1
17
19
Catch up on highlights from #ASCO25! Experts joined us at ASCO to share their insights on how the latest data could change clinical practice ➡️ Prof. @MarkSocinski: #NSCLC (downloadable slides also available) ➡️ Dr @AttardLab: #ProstateCancer ➡️ Dr @LizzySmyth1: #GastricCancer
0
0
0
Join Leading Experts & @COR2EDMedEd for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: https://t.co/7O0D3qP3WQ a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.
0
15
15
Join Leading Experts & @COR2EDMedEd for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: https://t.co/7O0D3qP3WQ Coming soon: a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE
0
13
14
🚨#ProstateCancer update from #ASCO25! 🚨 📊Insights on new data from the Phase 3 AMPLITUDE trial and a STAMPEDE Ancillary study From Prof. Gerhardt Attard (@AttardLab) How will these data impact clinical practice? Watch to find out 📺 See more updates from ASCO 2025:
0
0
1
Top Experts will Join @COR2EDMedEd at #ASCO25 for Rapid Video Insights on Late-Breaking Data, stay tuned for some Great Insights LINK: https://t.co/OQ877cYWOk In a series of short videos coming soon, Prof. Gerhardt Attard, first author on the AMPLITUDE study, will share
0
6
9
📢#ASCO25 is nearly here, keep a look out for our conference update! In this video, @giconnectInfo member Dr Lizzy Smyth introduces the medical experts who will be joining us at ASCO ➡️ Prof. @MarkSocinski: #NSCLC ➡️ Dr @AttardLab: #ProstateCancer ➡️ Dr @LizzySmyth1 :
0
0
1